Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up

1. Ludwig, H.
2. Greil, R.
3. Masszi, T.
4. Spicka, I.
5. Shpilberg, O.
6. Hajek, R.
7. Dmoszynska, A.
8. Paiva, B.
9. Vidriales, M.-B.
10. Esteves, G.
11. Stoppa, A.M.
12. Robinson, D.
13. Chaturvedi, S.
14. Ataman, O.
15. Enny, C.
16. Feng, H.
17. van de Velde, H.
18. Viterbo, L.